Carlos Ramos

15PUBLICATIONS
52CO-AUTHORS
Hybrid and electric vehicles and powertrainsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursModelling and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 13, 2024
CARs for Hodgkin: engine fine-tuning is in order.

Natalie S Grover, Carlos A Ramos

|Dec 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.

LaQuisa C Hill, Rayne H Rouce, Mengfen J Wu

|Jan 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu

|Mar 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.

David H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill

|Mar 23, 2022
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Leila Amini, Sara K Silbert, Shannon L Maude

|Mar 18, 2022
In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes.

Alireza Naghizadeh, Wei-Chung Tsao, Jong Hyun Cho

Pageof 3

Frequent Collaborators

7 joint publications

Helen E Heslop

7 joint publications

Premal Lulla

4 joint publications

Tao Wang

4 joint publications

LaQuisa Hill